The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Femasys sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Femasys Inc, United States Revenue

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Femasys is a medical device company that develops and manufactures medical device solutions for women’s healthcare. The company offers non-surgical female sterilization devices, and devices for the diagnosis of infertility, and cervical cancer diagnosis. Its products include femvue saline-air device, fembloc permanent contraceptive system and femcerv endocervical sampler. Femasys’s fembloc permanent contraceptive system is designed to permanently block the fallopian tubes in an innovative non-surgical approach. The company’s femcerv endocervical sampler is designed for sampling of the uterine cavity for cancer diagnosis. It caters to patient, physician, and healthcare system. Femasys is headquartered in Suwanee, Georgia, the US.

The key metrics of Femasys related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Femasys is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Femasys.

For a detailed understanding of the performance of Femasys, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.